NYSE:CHEHealthcare
Chemed (CHE) Stock After Recent Slide And DCF Upside Potential
If you are wondering whether Chemed is attractively priced or still has room to fall, the recent mix of returns and valuation signals gives you plenty to think about.
The stock last closed at US$436.27, with a gain of 3.7% over the past week, a slight decline of 0.9% over the last month, and returns of 2.9% year to date but a decline of 19.7% over the past year.
These moves put Chemed on the radar for investors who are reassessing what a fair price might look like after a period of weaker...